We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $544M
1-Year Est. Return 72.49%
This Fund
S&P 500
This Quarter Est. Return
+29.66%
1 Year Est. Return
+72.49%
3 Year Est. Return
+451.42%
5 Year Est. Return
10 Year Est. Return
AUM
$264M
AUM Growth
-$11.5M
Cap. Flow
-$7.86M
Cap. Flow %
-2.98%
Top 10 Hldgs %
54.79%
Holding
254
New
28
Increased
39
Reduced
42
Closed
104

Top Sells

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$6.06M
2
ESTC icon
Elastic
ESTC
+$4.73M
3
COIN icon
Coinbase
COIN
+$4.46M
4
AMD icon
Advanced Micro Devices
AMD
+$4.01M
5
STNE icon
StoneCo
STNE
+$3.81M

Sector Composition

Rank Sector Weight
1 Healthcare 35%
2 Technology 27.73%
3 Communication Services 14.29%
4 Miscellaneous 10.54%
5 Energy 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPOT icon
1
Spotify
SPOT
$113B
$20.4M 7.72%
257,700
-5,000
-2% -$403K
SHOP icon
2
Shopify
SHOP
$197B
$19.8M 7.51%
564,000
-28,000
-5% -$956K
SNOW icon
3
Snowflake
SNOW
$114B
$19.5M 7.4%
137,100
+16,550
+14% +$2.53M
PRQR icon
4
ProQR Therapeutics
PRQR
$323M
$18M 6.83%
5,344,446
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.24T
$13.3M 5.04%
150,398
+31,338
+26% +$2.98M
OXY.WS icon
6
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$12.3M 4.67%
304,889
+29,200
+11% +$1.35M
NET icon
7
Cloudflare
NET
$107B
$11.9M 4.51%
262,435
-17,500
-6% -$866K
MRK icon
8
Merck
MRK
$366B
$10.2M 3.87%
92,156
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$137B
$10.2M 3.87%
35,307
+6,807
+24% +$2.07M
ARWR icon
10
Arrowhead Research
ARWR
$12B
$8.87M 3.36%
221,015
+45,622
+26% +$1.51M
OXY icon
11
Occidental Petroleum
OXY
$59.1B
$8.68M 3.29%
139,400
-49,400
-26% -$3.36M
ZLAB icon
12
Zai Lab
ZLAB
$2.93B
$7.37M 2.8%
240,683
QURE icon
13
uniQure
QURE
$3.38B
$6.83M 2.59%
301,298
+62,300
+26% +$1.34M
ALBO
14
DELISTED
Albireo Pharma Inc
ALBO
$6.5M 2.47%
300,252
SPY icon
15
State Street SPDR S&P 500 ETF Trust
SPY
$825B
$5.86M 2.22%
+15,272
New +$5.87M
IONS icon
16
Ionis Pharmaceuticals
IONS
$10.1B
$5.56M 2.11%
148,807
HTZWW
17
Hertz Global Holdings Warrants
HTZWW
$86M
$5.41M 2.05%
732,504
+76,668
+12% +$676K
XYZ
18
Block Inc
XYZ
$50.2B
$5.03M 1.91%
80,000
+10,000
+14% +$617K
RARE icon
19
Ultragenyx Pharmaceutical
RARE
$2.52B
$4.82M 1.83%
106,741
+24,400
+30% +$960K
AMZN icon
20
Amazon
AMZN
$2.87T
$4.71M 1.79%
56,000
+17,663
+46% +$1.74M
GTLB icon
21
GitLab
GTLB
$7.58B
$4.47M 1.69%
97,200
+32,200
+50% +$1.45M
DDOG icon
22
Datadog
DDOG
$85.1B
$4.29M 1.63%
+58,000
New +$4.53M
WMT icon
23
Walmart Inc
WMT
$820B
$3.75M 1.42%
+79,050
New +$3.75M
CFLT
24
DELISTED
Confluent
CFLT
$3.74M 1.42%
+170,000
New +$3.94M
MRNA icon
25
Moderna
MRNA
$55.1B
$3.41M 1.29%
19,051
-2,400
-11% -$392K

Similar funds

Privium Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, Privium Fund Management held 254 positions worth $264M, down 4.2% from $275M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Privium Fund Management's Q4 2022 filing shows 28 new, 39 increased, 42 reduced and 104 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 15,272 shares worth $5.86M. The largest sale was Apellis Pharmaceuticals, an estimated $6.06M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

  • Privium Fund Management's largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 15,272 shares worth $5.86M.
  • Privium Fund Management added most to Alphabet (Google) Class A in Q4 2022, an estimated $2.98M increase.
  • Privium Fund Management's biggest Q4 2022 reduction was Occidental Petroleum, cutting an estimated $3.36M.
  • Privium Fund Management fully exited Apellis Pharmaceuticals in Q4 2022, selling an estimated $6.06M.
  • Privium Fund Management's ten largest holdings make up 55% of its $264M portfolio in Q4 2022.
  • Privium Fund Management opened 28 new positions and closed 104 in Q4 2022.
  • Privium Fund Management's portfolio value fell 4.2% quarter-over-quarter to $264M.

Based on Privium Fund Management's 13F filing for Q4 2022, filed 3 Feb 2023.